Table 2 Incidence of amputation and other vascular outcomes, mortality rate and costs per day among new users of SLGT-2 inhibitors, DPP-4 inhibitors, GLP-1 agonists, or other oral treatments for type 2 diabetes.

From: Association of antidiabetic therapies with lower extremity amputation, mortality and healthcare cost from a nationwide retrospective cohort study in Taiwan

Cohort

SGLT-2

DPP-4

GLP-1

Other

First cohort (excluding amputation during baseline)

Amputation, No

1

82

1

171

 Total No. of person-years

6,507.4

178,188.1

1,634.8

898,430.2

 Rate per 10 000 person-years

1.5

4.6

6.1

1.9

 Observation time, median (IQR), days

310 (90–464)

453 (255–488)

439.5 (151–480)

422 (116–481)

Death

7

1,246

3

4,713

 Total No. of person-years

6,507.9

178,221.1

1,635.0

898,513.5

 Rate per 10 000 person-years

10.8

69.9

18.3

52.5

 Observation time, median (IQR), days

310 (90–464)

453 (255–488)

439.5 (151–480)

422 (116–481)

Cost

    

 Total cost per day

235

253

364

174

 Emergency cost per day

3

6

6

6

 Inpatient cost per day

37

46

24

36

 Observation time, median (IQR), days

310 (90–464)

453 (255–488)

439.5 (152–480)

422 (116–481)

Second cohort (excluding any outcome during baseline)

Ulcer, No

10

303

3

1,167

 Total No. of person-years

6,294.1

170,468.9

1,577.7

867,221.7

 Rate per 10,000 person-years

15.9

17.8

19.0

13.5

 Observation time, median (IQR), days

310 (90–464)

453 (254–488)

440 (153–480)

420 (114–481)

Osteomyelitis

7

171

3

708

 Total No. of person-years

6,295.2

170,538.1

1,577.0

867,487.5

 Rate per 10,000 person-years

11.1

10.0

19.0

8.2

 Observation time, median (IQR), days

310 (90–464)

453 (254–488)

440 (154–480)

420 (115–481)

Peripheral vascular disease

71

2,257

16

10,999

 Total No. of person-years

6,257.6

169,326.0

1,569.3

861,726.2

 Rate per 10,000 person-years

113.5

133.3

102.0

127.6

 Observation time, median (IQR), days

304 (90–464)

452 (252–487)

439 (152–480)

415 (112–481)

Critical limb ischemia

0

31

1

97

 Total No. of person-years

6,298.4

170,622.8

1,577.7

867,799.1

 Rate per 10,000 person-years

0.0

1.8

6.3

1.1

 Observation time, median (IQR), days

310 (90–464)

453 (255–488)

440 (154–480)

420 (115–481)

  1. DPP-4, dipeptidyl peptidase 4; GLP-1, glucagon-like peptide 1; IQR, interquartile range; SGLT-2, sodium-glucose cotransporter 2.